alexa Attention Deficit Hyperactivity Disorder

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Attention Deficit Hyperactivity Disorder

Meta Description: Attention deficit hyperactivity disorder has been described as the most common neurodevelopmental disorder in childhood. When symptoms of Attention deficit hyperactivity disorder do not respond to methylphenidate or atomoxetine, some clinicians start looking for alternative explanations.

Attention deficit hyperactivity disorder has been described as the most common neurodevelopmental disorder in childhood. Attention deficit hyperactivity disorder is characterized by symptoms of inattention, hyperactivity and impulsivity occurring in 3-8% of school-aged children in the general population. Several studies have drawn attention to the frequent occurrence of epileptic seizures and electroencephalographic abnormalities in children with Attention deficit hyperactivity disorder.

At least 20% of children with epilepsy have symptoms of Attention deficit hyperactivity disorder as comorbidity. Psychostimulants such as methylphenidate and noradrenergic potentiation such as atomoxetine are generally the most effective medication for children with Attention deficit hyperactivity disorder. When symptoms of Attention deficit hyperactivity disorder do not respond to methylphenidate or atomoxetine, some clinicians start looking for alternative explanations.

For more details: https://www.omicsonline.org/open-access/eeg-abnormalities-in-adhd-how-should-we-treat-2161-0665.1000e122.php?aid=22733

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger